Home Generics Biosimilars Docs & Positions Facts & Figures Press Room Conferences

Pricing & Reimbursement

TopPricing & Reimbursement Systems

a) European Pharmaceutical Markets
Sustaining Generic Medicines Markets in Europe Sustaining Generic Medicines Markets in Europe


The EU is not realising the full potential for savings from generic medicines. This study shows that added savings of 27%-48% could be attained if the appropriate measures were taken.
Coordinated government policies are critically needed in many EU countries to foster a sustainable generic medicines industry that plays an important role in the overall competi-tiveness of the EU pharmaceutical industry.


By Prof Dr Steven Simoens,
Katholieke Universiteit Leuven
• April 2006